CNBC June 27, 2024
Annika Kim Constantino

Key Points

– Walgreens reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook due to a “challenging” environment for pharmacies and U.S. consumers.

– The company topped revenue estimates for the quarter on strong performance in its health-care segment.

– The results come as Walgreens works to slash costs by closing underperforming U.S. stores, among other efforts.

Shares of Walgreens plunged more than 20% on Thursday after the company reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook, citing a “challenging” environment for pharmacies and U.S. consumers.

The retail pharmacy giant now expects fiscal 2024 adjusted earnings of $2.80 to $2.95 per share. That compares...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Pharma, Pharma / Biotech, Provider, Retailer
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation

Share Article